Clinical ResearchComparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction
Under an Elsevier user license
open archive
Central Illustration
Key Words
heart failure
hospitalization
medication
mortality
sacubitril-valsartan
Abbreviations and Acronyms
ACE
angiotensin-converting enzyme inhibitor
ARB
angiotensin receptor blocker
CI
confidence interval
HF
heart failure
HFrEF
heart failure with reduced ejection fraction
HR
hazard ratio
ICD
implantable cardioverter-defibrillator
Cited by (0)
Dr. Shah has received grants from Centers for Medicare & Medicaid Services (CMS)/Center for Medicare & Medicaid Innovation (CMMI), Food and Drug Administration (FDA), Agency for Healthcare Research and Quality (AHRQ), National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI), and National Science Foundation (NSF). Dr. S.J. Sangaralingham has received grants from the NIH and the FDA. Dr. Dunlay has received grants from the NIH and from the Patient Centered Outcomes Research Institute to develop a Clinical Data Research Network. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
© 2020 by the American College of Cardiology Foundation. Published by Elsevier.